BRIEF-TG Therapeutics announces orphan drug designation for TGR-1202 for treatment of chronic lymphocytic leukemia

* TG Therapeutics announces orphan drug designation for

TGR-1202 for treatment of chronic lymphocytic leukemia

Source text for Eikon:

Further company coverage:

Read more